Erech Finance Cahalacha (XTAE:EFNC) 3-Year Revenue Growth Rate : -72.80% (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Erech Finance Cahalacha 3-Year Revenue Growth Rate?

Erech Finance Cahalacha's Revenue per Share for the six months ended in Dec. 2023 was ₪0.06.

During the past 12 months, Erech Finance Cahalacha's average Revenue per Share Growth Rate was -97.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -72.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was -45.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of Erech Finance Cahalacha was 0.90% per year. The lowest was -72.80% per year. And the median was -50.35% per year.

Competitive Comparison of Erech Finance Cahalacha's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Erech Finance Cahalacha's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Erech Finance Cahalacha's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Erech Finance Cahalacha's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Erech Finance Cahalacha's 3-Year Revenue Growth Rate falls into.

Erech Finance Cahalacha 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Erech Finance Cahalacha (XTAE:EFNC) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Erech Finance Cahalacha 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Erech Finance Cahalacha's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Erech Finance Cahalacha (XTAE:EFNC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Erech Finance Cahalacha Ltd (XTAE:EFNC) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yakov Eliav 5, Downtown, Jerusalem, ISR

Website

http://www.insuline-medical.com

Erech Finance Cahalacha Ltd, formerly Insuline Medical Ltd is a medical device company. It develops & markets technologies to the clinical effectiveness of devices & drugs for the treatment of diabetes. Its products include the InsuPatch device for insulin pump users, & the InsuPad device for injection users. The InsuPad is a company's flagship product.

Erech Finance Cahalacha (XTAE:EFNC) Headlines

No Headlines